著者名,論文名,雑誌名,ISSN,出版者名,出版日付,巻,号,ページ,URL,URL(DOI)
"森田, 智視 and Imagawa, Jun and Tanaka, Hideo and Nakamae, Hirohisa and Hino, Masayuki and Murai, Kazunori and Ishida, Yoji and Kumagai, Takashi and Sato, Seiichi and Ohashi, Kazuteru and Sakamaki, Hisashi and Wakita, Hisashi and Uoshima, Nobuhiko and Nakagawa, Yasunori and Minami, Yosuke and Ogasawara, Masahiro and Takeoka, Tomoharu and Akasaka, Hiroshi and Utsumi, Takahiko and Uike, Naokuni and Sato, Tsutomu and Ando, Sachiko and Usuki, Kensuke and Mizuta, Syuichi and Hashino, Satoshi and Nomura, Tetsuhiko and Shikami, Masato and Fukutani, Hisashi and Ohe, Yokiko and Kosugi, Hiroshi and Shibayama, Hirohiko and Maeda, Yasuhiro and Fukushima, Toshihiro and Yamazaki, Hirohito and Tsubaki, Kazuo and Kukita, Toshimasa and Adachi, Yoko and Nataduka, Toshiki and Sakoda, Hiroto and Yokoyama, Hisayuki and Okamoto, Takahiro and Shirasugi, Yukari and Onishi, Yasushi and Nohgawa, Masaharu and Yoshihara, Satoshi and Morita, Satoshi and Sakamoto, Junichi and Kimura, Shinya and DADI Trial Group, Japan","Final 3-year results of the dasatinib discontinuation trial in patients with chronic myeloid leukemia who received dasatinib as a second-line treatment, clin lymphoma",Clinical Lymphoma Myeloma and Leukemia,2152-2650,Elsevier BV,2018-05,18,5,353-360.e1,https://cir.nii.ac.jp/crid/1050282810834206976,https://doi.org/10.1016/j.clml.2018.03.004